|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.
There are no as such competitors for TScan Therapeutics.
The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by Cowen & Co. on August 13, 2021. The analyst firm set a price target for 0.00 expecting TCRX to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for TScan Therapeutics (NASDAQ: TCRX) is $6.24 last updated Fri Sep 17 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for TScan Therapeutics. The last dividend paid out to investors was $0.07 on June 14, 2018.
There is no upcoming split for TScan Therapeutics.
TScan Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.